Shares in Philadelphia-based cannabis company FSD Pharma spiked 324% in premarket trading this morning on news that it had been granted approval by the Food and Drug Administration to submit an application for a clinical trial using a synthetic drug that mimics the action of a molecule found in marijuana to treat COVID-19.
Cramps can range from mildly uncomfortable to downright debilitating, making it impossible for people to complete their daily responsibilities.